Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Osteoporosis 2Neoplasms 2Multiple Myeloma 2Back Pain 2Spinal Fractures 1Spinal Diseases 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Ibandronic Acid 5Zoledronic Acid 3Denosumab 3pembrolizumab 2Sunitinib 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Methods 2Interviews as Topic 2Injections 2Curettage 2selinexor 1saracatinib 1ridaforolimus 1radium Ra 223 dichloride 1pegfilgrastim 1olaparib 1montanide ISA 51 1lentiviral minigene vaccine of COVID-19 coronavirus 1endostar protein 1cc-486 1angiotensin I (1-7) 1Vincristine 1Transplantation, Homologous 1Transplantation, Autologous 1Transcranial Direct Current Stimulation 1Trabectedin 1Tomography, Spiral Computed 1TES 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bone Neoplasms × Kyphoplasty × Clear all
NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

Medtronic Spinal and Biologics

Phase 4 Completed
300 enrolled
Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡